These findings suggest that suppression of PRR5L expression might promote TNFα-associated autoimmune diseases, including common conditions such as asthma, rheumatoid arthritis, psoriasis, or inflammatory bowel disease. The gene discussed is PRR5L; the disease is inflammatory bowel disease.